Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies

Clinical trial NCT01419704 · WITHDRAWN

Trial details

NCT number: NCT01419704
Sponsor: Talaris Therapeutics Inc.
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anemia, Sickle Cell Complex and Transfusion-dependent Hemoglobinopathies Thalassemia Diamond-Blackfan Anemia Bone Marrow Failure Syndromes Alpha-Thalassemia Beta-Thalassemia

Start date: 2011-05-01
Primary completion: 2016-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.